Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-24

Clinical Trial Update: A Study Comparing The Safety, Tolerability and Efficacy of Trizivir VS Combivir & Atazanavir In Subjects With HIV [Phase 4]

View source ↗

Summary

This Phase 4 trial evaluated the safety, tolerability, and efficacy of Trizivir compared with Combivir plus Atazanavir in people with HIV; the study has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ATAZANAVIR (atazanavir)
  • COMBIVIR (Lamivudine and Zidovudine)
  • Trizivir

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infection, Human Immunodeficiency Virus I, HIV Infection | Phase 4 | Status: COMPLETED